• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病急性加重期早期有细菌感染和无细菌感染患者的血浆氨基酸水平差异

Differences in plasma amino acid levels in patients with and without bacterial infection during the early stage of acute exacerbation of COPD.

作者信息

Inoue Saki, Ikeda Hideki

机构信息

Department of Nutritional Management, Sanyudo Hospital, Yonezawa, Japan.

Pulmonary Division, Department of Internal Medicine, Sanyudo Hospital, Yonezawa, Japan,

出版信息

Int J Chron Obstruct Pulmon Dis. 2019 Mar 1;14:575-583. doi: 10.2147/COPD.S188422. eCollection 2019.

DOI:10.2147/COPD.S188422
PMID:30880947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6402618/
Abstract

PURPOSE

No consensus has been reached regarding appropriate nutritional intervention and rehabilitation during early acute exacerbation of COPD (AECOPD). Given the individual differences in symptoms of AECOPD, patients should be classified by their pathology. For example, it is known that there are differences in the inflammatory response between AECOPD with and without bacterial infection. However, there have been few reports on AECOPD from a nutritional perspective. The aim of this study was to investigate amino acid levels in patients with AECOPD.

PATIENTS AND METHODS

Blood was collected from patients who were hospitalized with AECOPD and from patients with COPD that was in a stable state. We divided the patients with AECOPD into those without bacterial infection (group A) and those with bacterial infection (group B). The patients with COPD that was stable served as controls (group C). The plasma levels of 9 essential amino acids, 13 nonessential amino acids, and total amino acids were compared between the three groups.

RESULTS

In the early stages of AECOPD, differences in plasma levels of only three amino acids (glycine, phenylalanine, and arginine) were observed between groups C and A. Differences in total amino acids and 13 amino acids were observed between groups C and B. Group B had lower levels of total amino acids and of seven amino acids (asparagine, citrulline, glutamine, histidine, methionine, serine, and threonine) compared with the other study groups.

CONCLUSION

The findings of this study show that amino acid levels in plasma differ in patients with AECOPD depending on whether or not bacterial infection is present. Our results suggest that specific amino acids (ie, asparagine, citrulline, glutamine, histidine, serine, and threonine) have potential utility as diagnostic markers to distinguish between bacterial and nonbacterial AECOPD.

摘要

目的

关于慢性阻塞性肺疾病急性加重期(AECOPD)早期合适的营养干预和康复措施尚未达成共识。鉴于AECOPD症状存在个体差异,应根据患者的病理情况进行分类。例如,已知合并和未合并细菌感染的AECOPD在炎症反应方面存在差异。然而,从营养角度对AECOPD的报道较少。本研究的目的是调查AECOPD患者的氨基酸水平。

患者与方法

采集因AECOPD住院的患者以及处于稳定期的慢性阻塞性肺疾病(COPD)患者的血液。我们将AECOPD患者分为未合并细菌感染组(A组)和合并细菌感染组(B组)。处于稳定期的COPD患者作为对照组(C组)。比较三组患者血浆中9种必需氨基酸、13种非必需氨基酸和总氨基酸的水平。

结果

在AECOPD早期,C组和A组之间仅观察到三种氨基酸(甘氨酸、苯丙氨酸和精氨酸)的血浆水平存在差异。C组和B组之间观察到总氨基酸和13种氨基酸存在差异。与其他研究组相比,B组的总氨基酸水平以及七种氨基酸(天冬酰胺、瓜氨酸、谷氨酰胺、组氨酸、蛋氨酸、丝氨酸和苏氨酸)水平较低。

结论

本研究结果表明,AECOPD患者血浆中的氨基酸水平因是否存在细菌感染而有所不同。我们的结果表明,特定氨基酸(即天冬酰胺、瓜氨酸、谷氨酰胺、组氨酸、丝氨酸和苏氨酸)有可能作为区分细菌性和非细菌性AECOPD的诊断标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4731/6402618/dc82ef38af24/copd-14-575Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4731/6402618/5a3b3b3dbfec/copd-14-575Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4731/6402618/caabbc137162/copd-14-575Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4731/6402618/dc82ef38af24/copd-14-575Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4731/6402618/5a3b3b3dbfec/copd-14-575Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4731/6402618/caabbc137162/copd-14-575Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4731/6402618/dc82ef38af24/copd-14-575Fig3.jpg

相似文献

1
Differences in plasma amino acid levels in patients with and without bacterial infection during the early stage of acute exacerbation of COPD.慢性阻塞性肺疾病急性加重期早期有细菌感染和无细菌感染患者的血浆氨基酸水平差异
Int J Chron Obstruct Pulmon Dis. 2019 Mar 1;14:575-583. doi: 10.2147/COPD.S188422. eCollection 2019.
2
Phenotyping and outcomes of hospitalized COPD patients using rapid molecular diagnostics on sputum samples.利用痰液样本的快速分子诊断技术对住院慢性阻塞性肺疾病患者进行表型分析及评估预后
Int J Chron Obstruct Pulmon Dis. 2019 Jan 23;14:311-319. doi: 10.2147/COPD.S188186. eCollection 2019.
3
Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data.新诊断或未接受过维持治疗的慢性阻塞性肺疾病患者的急性加重恢复模式:TICARI 1试验数据的二次分析
Int J Chron Obstruct Pulmon Dis. 2018 May 10;13:1515-1525. doi: 10.2147/COPD.S149669. eCollection 2018.
4
Relationship between the GOLD combined COPD assessment staging system and bacterial isolation.慢性阻塞性肺疾病全球倡议(GOLD)综合评估分期系统与细菌分离之间的关系
Int J Chron Obstruct Pulmon Dis. 2014 Sep 27;9:1045-51. doi: 10.2147/COPD.S70620. eCollection 2014.
5
Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期患者血浆 B 型利钠肽水平的变化。
Int J Chron Obstruct Pulmon Dis. 2014 Feb 5;9:155-62. doi: 10.2147/COPD.S55143. eCollection 2014.
6
Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note.血清降钙素原在慢性阻塞性肺疾病急性加重患者中的应用价值:一个警示。
Int J Chron Obstruct Pulmon Dis. 2012;7:127-35. doi: 10.2147/COPD.S29149. Epub 2012 Feb 23.
7
Serum levels of IGFBP7 are elevated during acute exacerbation in COPD patients.慢性阻塞性肺疾病(COPD)患者急性加重期血清胰岛素样生长因子结合蛋白7(IGFBP7)水平升高。
Int J Chron Obstruct Pulmon Dis. 2017 Jun 19;12:1775-1780. doi: 10.2147/COPD.S132652. eCollection 2017.
8
Biomarkers of Prothrombotic State and Risk Assessment of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者血栓前状态的生物标志物及加重风险评估。
Int J Chron Obstruct Pulmon Dis. 2024 Oct 11;19:2273-2283. doi: 10.2147/COPD.S466563. eCollection 2024.
9
Acute Exacerbation and Respiratory InfectionS in COPD (AERIS): protocol for a prospective, observational cohort study.慢性阻塞性肺疾病急性加重与呼吸道感染研究(AERIS):一项前瞻性观察队列研究方案
BMJ Open. 2014 Mar 7;4(3):e004546. doi: 10.1136/bmjopen-2013-004546.
10
Progranulin is a novel biomarker for predicting an acute exacerbation of chronic obstructive pulmonary disease.颗粒蛋白前体是预测慢性阻塞性肺疾病急性加重的一种新型生物标志物。
Clin Respir J. 2018 Oct;12(10):2525-2533. doi: 10.1111/crj.12952. Epub 2018 Sep 23.

引用本文的文献

1
Reduced plasma glycine concentration in healthy and chronically diseased older adults: a marker of visceral adiposity?健康和慢性疾病老年人血浆甘氨酸浓度降低:内脏肥胖的标志物?
Am J Clin Nutr. 2024 Jun;119(6):1455-1464. doi: 10.1016/j.ajcnut.2024.04.008. Epub 2024 Apr 12.
2
Exploration of biomarkers for efficacy evaluation of traditional Chinese medicine syndromes of acute exacerbation of chronic obstructive pulmonary disease based on metabolomics.基于代谢组学探索慢性阻塞性肺疾病急性加重期中医证候疗效评价的生物标志物
Front Pharmacol. 2024 Jan 26;15:1302950. doi: 10.3389/fphar.2024.1302950. eCollection 2024.
3

本文引用的文献

1
Outcomes after early and delayed rehabilitation for exacerbation of chronic obstructive pulmonary disease: a nationwide retrospective cohort study in Japan.慢性阻塞性肺疾病急性加重期早期与延迟康复的结局:日本一项全国性回顾性队列研究
Respir Res. 2017 Apr 21;18(1):68. doi: 10.1186/s12931-017-0552-7.
2
Plasma metabolomics for the diagnosis and prognosis of H1N1 influenza pneumonia.血浆代谢组学在 H1N1 流感肺炎诊断和预后中的应用。
Crit Care. 2017 Apr 19;21(1):97. doi: 10.1186/s13054-017-1672-7.
3
The recent advances of phenotypes in acute exacerbations of COPD.
Jian-Ti-Kang-Yi decoction alleviates poly(I:C)-induced pneumonia by inhibiting inflammatory response, reducing oxidative stress, and modulating host metabolism.
健体康益汤通过抑制炎症反应、减轻氧化应激和调节宿主代谢来缓解聚肌胞苷酸(poly(I:C))诱导的肺炎。
Front Pharmacol. 2022 Sep 6;13:979400. doi: 10.3389/fphar.2022.979400. eCollection 2022.
4
Reprogramming of Amino Acid Metabolism Differs between Community-Acquired Pneumonia and Infection-Associated Exacerbation of Chronic Obstructive Pulmonary Disease.氨基酸代谢重编程在社区获得性肺炎和感染相关慢性阻塞性肺疾病加重中存在差异。
Cells. 2022 Jul 24;11(15):2283. doi: 10.3390/cells11152283.
5
Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis.生物标志物指导慢性阻塞性肺疾病急性加重(AECOPD)抗生素使用:系统评价和荟萃分析。
BMC Pulm Med. 2022 May 13;22(1):194. doi: 10.1186/s12890-022-01958-4.
6
Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients.口腔细菌疗法可降低新冠病毒感染患者慢性疲劳的发生率。
Front Nutr. 2022 Jan 12;8:756177. doi: 10.3389/fnut.2021.756177. eCollection 2021.
7
The Central Role of Clinical Nutrition in COVID-19 Patients During and After Hospitalization in Intensive Care Unit.临床营养在重症监护病房住院期间及出院后的新冠患者中的核心作用
SN Compr Clin Med. 2020;2(8):1064-1068. doi: 10.1007/s42399-020-00410-0. Epub 2020 Jul 15.
8
Epithelial Dysfunction in Lung Diseases: Effects of Amino Acids and Potential Mechanisms.肺部疾病中的上皮功能障碍:氨基酸的作用及潜在机制。
Adv Exp Med Biol. 2020;1265:57-70. doi: 10.1007/978-3-030-45328-2_4.
慢性阻塞性肺疾病急性加重期表型的最新进展。
Int J Chron Obstruct Pulmon Dis. 2017 Mar 27;12:1009-1018. doi: 10.2147/COPD.S128604. eCollection 2017.
4
Tryptophan catabolism in acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期的色氨酸分解代谢
Int J Chron Obstruct Pulmon Dis. 2016 Sep 29;11:2435-2446. doi: 10.2147/COPD.S107844. eCollection 2016.
5
Arginines Plasma Concentration and Oxidative Stress in Mild to Moderate COPD.轻至中度慢性阻塞性肺疾病患者的精氨酸血浆浓度与氧化应激
PLoS One. 2016 Aug 1;11(8):e0160237. doi: 10.1371/journal.pone.0160237. eCollection 2016.
6
Alterations in whole-body arginine metabolism in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中全身精氨酸代谢的改变
Am J Clin Nutr. 2016 Jun;103(6):1458-64. doi: 10.3945/ajcn.115.125187. Epub 2016 May 4.
7
Exogenous Glutamine in Respiratory Diseases: Myth or Reality?外源性谷氨酰胺在呼吸系统疾病中的应用:神话还是现实?
Nutrients. 2016 Feb 4;8(2):76. doi: 10.3390/nu8020076.
8
Dynamic changes in amino acid concentration profiles in patients with sepsis.脓毒症患者氨基酸浓度谱的动态变化
PLoS One. 2015 Apr 7;10(4):e0121933. doi: 10.1371/journal.pone.0121933. eCollection 2015.
9
An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial.慢性呼吸疾病加重住院期间早期康复干预以促进恢复:随机对照试验。
BMJ. 2014 Jul 8;349:g4315. doi: 10.1136/bmj.g4315.
10
Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics.COPD 气促加重和非气促加重:炎症反应和临床特征。
Chest. 2013 Oct;144(4):1134-1142. doi: 10.1378/chest.13-0488.